{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:30:49Z","timestamp":1771500649072,"version":"3.50.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Oral antineoplastic agents have caused a paradigm shift in cancer treatment, however, they produce many unique challenges. Although oral antineoplastics can have complex administration regimes, low adherence rates and high possibilities of drug-drug interactions, they are administered unsupervised at home. Cancer services pharmacists have the required skillsets to improve patient outcomes associated with oral antineoplastic treatment by increasing patient health literacy, improving concordance and optimising administration protocols.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Aim<\/jats:title>\n<jats:p>To evaluate patients\u2019 perceptions, experiences and overall satisfaction with dedicated clinical pharmacist consultations in patients treated with oral antineoplastic agents at a major public hospital.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Method<\/jats:title>\n<jats:p>In this retrospective cross-sectional study at a quaternary hospital in Western Australia, data were collected by a paper questionnaire (mailed in March 2022) to a random sample of 191 patients initiated on oral antineoplastic drugs between January 2021 and February 2022. Demographics, prescribed antineoplastic drug\/s, cancer type data were collected including using 5-point Likert scale questions assess patients\u2019 overall satisfaction with the clinical pharmacist consultations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>The questionnaire response rate was 27.7% (52\/188) (mean age 63.2 years; 57.5% female). Most patients (42\/52; 80.8%) were satisfied with pharmacist consultations, trusted the pharmacist\u2019s advice (45\/52; 86.5%), considered that the pharmacist improved their understanding of how to manage side effects (43\/52; 82.7%) and they provided an important service in outpatient care (45\/52; 86.5%).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Overall, patients reported positive perceptions, experiences, and satisfaction with the cancer services pharmacist counselling services during their oral antineoplastic treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0304011","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:53:31Z","timestamp":1718301211000},"page":"e0304011","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of patient perceptions of counselling on oral antineoplastic agents by a dedicated cancer services pharmacist in an outpatient cancer clinic"],"prefix":"10.1371","volume":"19","author":[{"given":"Lorna","family":"McNabb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Metrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Ferrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tandy-Sue","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan","family":"Corscadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7212-0667","authenticated-orcid":true,"given":"Petra","family":"Czarniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"4","key":"pone.0304011.ref001","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1078155217753889","article-title":"Impact of a formal pharmacist-run oral antineoplastic monitoring program: A pilot study in an adult genitourinary oncology clinic","volume":"25","author":"B Conliffe","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"8","key":"pone.0304011.ref002","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1177\/1078155219859424","article-title":"Demonstrating the value of the oncology pharmacist within the healthcare team","volume":"25","author":"E M Segal","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"pone.0304011.ref003","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.2147\/PPA.S432821","article-title":"Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review","author":"HY Yeo","year":"2023","journal-title":"Patient Prefer Adherence"},{"issue":"S4","key":"pone.0304011.ref004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1634\/theoncologist.6-suppl_4-12","article-title":"Answering patients\u2019 needs: oral alternatives to intravenous therapy","volume":"6","author":"M Borner","year":"2001","journal-title":"The oncologist"},{"issue":"11","key":"pone.0304011.ref005","doi-asserted-by":"crossref","first-page":"e1282","DOI":"10.1200\/OP.20.00295","article-title":"Providing oncology pharmacy services during the coronavirus pandemic: French Society for Oncology Pharmacy (Soci\u00e9t\u00e9 Francaise de Pharmacie Oncologique [SFPO]) guidelines","volume":"16","author":"B Pourroy","year":"2020","journal-title":"JCO Oncology Practice"},{"issue":"S3","key":"pone.0304011.ref006","doi-asserted-by":"crossref","first-page":"S-1","DOI":"10.6004\/jnccn.2008.2003","article-title":"National Comprehensive Cancer Network (NCCN) task force report: oral chemotherapy","volume":"6","author":"SN Weingart","year":"2008","journal-title":"J Natl Compr Cancer Netw"},{"issue":"9","key":"pone.0304011.ref007","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/94.9.652","article-title":"Adherence to therapy with oral antineoplastic agents","volume":"94","author":"AH Partridge","year":"2002","journal-title":"JNCI"},{"issue":"4","key":"pone.0304011.ref008","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1078155210389216","article-title":"Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?","volume":"17","author":"AD Ruder","year":"2011","journal-title":"J Oncol Pharm Pract"},{"key":"pone.0304011.ref009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2354.2010.01199.x","article-title":"Considerations when choosing oral chemotherapy: identifying and responding to patient need","volume":"19","author":"S Irshad","year":"2010","journal-title":"Eur J Cancer"},{"issue":"7","key":"pone.0304011.ref010","doi-asserted-by":"crossref","first-page":"e003139","DOI":"10.1136\/bmjopen-2013-003139","article-title":"Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study","volume":"3","author":"L Krolop","year":"2013","journal-title":"BMJ open"},{"issue":"18","key":"pone.0304011.ref011","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1200\/JCO.20.03088","article-title":"The randomized AMBORA trial: Impact of pharmacological\/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents","volume":"39","author":"P D\u00fcrr","year":"2021","journal-title":"J Clinical Oncol"},{"issue":"3","key":"pone.0304011.ref012","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/1078155215581524","article-title":"Physician\u2013pharmacist collaboration for oral chemotherapy monitoring: insights from an academic genitourinary oncology practice","volume":"22","author":"LM Holle","year":"2016","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"pone.0304011.ref013","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1078155215612541","article-title":"Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer","volume":"22","author":"JM Patel","year":"2016","journal-title":"J Oncol Pharm Pract"},{"issue":"8","key":"pone.0304011.ref014","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1078155216672314","article-title":"The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy","volume":"23","author":"B Battis","year":"2017","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"pone.0304011.ref015","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1177\/1078155218798138","article-title":"Impact of pharmacy collaborating services in an outpatient clinic on improving adverse drug reactions in outpatient cancer chemotherapy","volume":"25","author":"H Suzuki","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"pone.0304011.ref016","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1078155216655473","article-title":"Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents","volume":"23","author":"M Kimura","year":"2017","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"pone.0304011.ref017","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1200\/JOP.17.00039","article-title":"Improved adherence rates and clinical outcomes of an integrated, closed-loop, pharmacist-led oral chemotherapy management program","volume":"14","author":"B Muluneh","year":"2018","journal-title":"J Oncol Pract"},{"issue":"1","key":"pone.0304011.ref018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1078155216671189","article-title":"Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center","volume":"24","author":"LA Randolph","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"pone.0304011.ref019","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/PPA.S106629","article-title":"Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature","volume":"10","author":"D Eek","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"pone.0304011.ref020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1078155210389217","article-title":"Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic","volume":"17","author":"M McKee","year":"2011","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"pone.0304011.ref021","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1078155220950412","article-title":"Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction","volume":"27","author":"L Munro","year":"2021","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"pone.0304011.ref022","first-page":"115","article-title":"SHPA Standards of Practice for the Provision of Clinical Oncology Pharmacy Services; The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology","volume":"32","author":"J Davis","year":"2002","journal-title":"JPPR"},{"key":"pone.0304011.ref023","unstructured":"The Society of Hospital Pharmacists of Australia. SHPA response to The Australian Cancer Plan 2023\u20132033 Consultation\u2013via online survey March 2022 2022. https:\/\/shpa.org.au\/publicassets\/798644f8-339f-ec11-90fe-00505696223b\/shpa_response_to_the_australian_cancer_plan_2023-2033_consultation_-_mar2022.pdf https:\/\/shpa.org.au\/publicassets\/798644f8-339f-ec11-90fe-00505696223b\/shpa_response_to_the_australian_cancer_plan_2023-2033_consultation_-_mar2022.pdf."},{"issue":"3","key":"pone.0304011.ref024","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1111\/ajco.12267","article-title":"Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinic","volume":"12","author":"C Walter","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"issue":"4","key":"pone.0304011.ref025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/ajco.13887","article-title":"Specialist pharmacist consultations with cancer patients in a pharmacist\u2010led anticancer clinic","volume":"19","author":"J Soggee","year":"2023","journal-title":"Asia Pac J Clin Oncol"},{"issue":"5","key":"pone.0304011.ref026","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s13187-022-02203-6","article-title":"Correction to: Cross-sectional Census Survey of Patients With Cancer who Received a Pharmacist Consultation in a Pharmacist Led Anti-cancer Clinic","volume":"37","author":"M Dennis","year":"2022","journal-title":"J Cancer Educ"},{"issue":"1","key":"pone.0304011.ref027","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/pharmacy8010046","article-title":"Evaluation of a pharmacist led oral chemotherapy clinic: A pilot program in the gastrointestinal oncology clinic at an academic medical center","volume":"8","author":"JO Darling","year":"2020","journal-title":"Pharmacy"},{"key":"pone.0304011.ref028","first-page":"19","article-title":"Exploring perceptions and experiences of oral chemotherapy in people with cancer","author":"A Costa","year":"2020","journal-title":"Cancer Nurs Pract"},{"key":"pone.0304011.ref029","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11096-015-0235-8","article-title":"Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction","volume":"38","author":"A Ribed","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"pone.0304011.ref030","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1177\/10781552211039501","article-title":"Implementation and outcomes of a pharmacist-led oral chemotherapy clinic at VA Maine Healthcare System","volume":"28","author":"W Sargent","year":"2022","journal-title":"J Oncol Pharm Pract"},{"key":"pone.0304011.ref031","first-page":"130","article-title":"The expanding role of the oncology pharmacist","author":"LM Holle","year":"2020","journal-title":"MDPI"},{"issue":"1","key":"pone.0304011.ref032","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1078155218783814","article-title":"A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies","volume":"25","author":"S Maleki","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"8","key":"pone.0304011.ref033","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1177\/10781552231159870","article-title":"The impact of a pharmacist-led oral anticancer clinic on medication adherence and laboratory monitoring","volume":"29","author":"A Megeed","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"pone.0304011.ref034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1525-1497.2003.20114.x","article-title":"Are older patients more satisfied with hospital care than younger patients?","volume":"18","author":"CK Jaipaul","year":"2003","journal-title":"J Gen Intern Med"},{"issue":"4","key":"pone.0304011.ref035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1377\/hlthaff.10.4.254","article-title":"Patients evaluate their hospital care: a national survey","volume":"10","author":"PD Cleary","year":"1991","journal-title":"Health Affair"},{"issue":"1","key":"pone.0304011.ref036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01324054","article-title":"The significance of patients\u2019 perceptions of physician conduct: a study of patient satisfaction in a family practice centre","volume":"6","author":"MR DiMatteo","year":"1980","journal-title":"J Commun Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:53:51Z","timestamp":1718301231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304011"}},"subtitle":[],"editor":[{"given":"Yaser Mohammed","family":"Al-Worafi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0304011","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}